•
Sep 30, 2022

Stoke Therapeutics Q3 2022 Earnings Report

Total Revenue
$2.91M
EPS
-$0.66
Previous year: -$0.61
+8.2%
Gross Profit
$1.98M
Cash and Equivalents
$113M
Previous year: $149M
-23.9%
Free Cash Flow
-$24.1M
Previous year: -$15M
+61.1%
Total Assets
$278M
Previous year: $254M
+9.4%

Stoke Therapeutics

Stoke Therapeutics